← Back to headlines
H.C. Wainwright Raises Price Target for ImmunityBio to $15
H.C. Wainwright has increased its price target for ImmunityBio, Inc. (IBRX) to $15 from $10, maintaining a Buy rating on the company's shares.
6 Mar, 15:20 — 6 Mar, 15:20
Sources
Showing 1 of 1 sources
